FDA Panel Supports Broader Access to Peptides, Including BPC-157

An FDA advisory committee has voted to recommend adding the popular peptide BPC-157 to the drug compounding list, a move that supports broader public access to peptides like the so-called Wolverine peptide despite scientist objections and warnings about risks.